fluorouracil has been researched along with morin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chung, SS; Dwabe, S; Oliva, B; Vadgama, JV | 1 |
| Caselli, A; Cirri, P; Livi, L; Lori, G; Mangoni, M; Marzocchini, R; Paoli, P; Raugei, G; Talamonti, C | 1 |
3 other study(ies) available for fluorouracil and morin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flavonoids; Fluorouracil; HT29 Cells; Humans; Mice; Neoplastic Stem Cells; NIH 3T3 Cells; Phosphorylation; STAT3 Transcription Factor; Telomerase | 2016 |
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy; Flavonoids; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Melanoma; Molecular Targeted Therapy; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Radiation Tolerance; Radiotherapy; Up-Regulation | 2018 |